# Acibadem Sistina Hospital

Source: https://onco.cc/institutions/acibadem-sistina-hospital/  
OnCo record `acibadem-sistina-hospital` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A private clinical hospital in Skopje with an oncology department that gives chemotherapy, hormone treatment, immunotherapy, targeted drugs and radiotherapy, and has taken part in international cancer drug trials.

## Summary

Acibadem Sistina opened as a clinical hospital on 7 April 2010, growing from a gynaecology and obstetrics hospital opened in 2001; it describes itself as accredited by Joint Commission International and gives 1,159 staff including 228 doctors. Its oncology department plans treatment through a multidisciplinary team, uses PET/CT for detection and follow-up, offers chemotherapy, hormone therapy, immunotherapy and targeted therapy, and delivers radiotherapy on Varian TrueBeam and Trilogy linear accelerators. It lists breast, brain, lung, colorectal, stomach, pancreatic, liver, prostate, uterine, ovarian, bladder, testicular, head and neck, bone and soft tissue cancers among those it treats most often. ClinicalTrials.gov lists it as a site of CLEOPATRA (NCT00567190), ALINA (NCT03456076), lidERA (NCT04961996) and a trastuzumab emtansine extension study (NCT00781612). The coordinates are OpenStreetMap's point for the hospital at Skupi 5A.

## Fields

- Kind: Institution
- Last checked: 2026-11-11
- Also known as: Аџибадем Систина; Private Health Organization Acibadem Sistina Hospital
- City: Skopje, MK
- Type: hospital
- Website: https://acibademsistina.mk/

## Sources

- Acibadem Sistina: oncology department (in Macedonian): https://acibademsistina.mk/mk/home/oddel/42
- Acibadem Sistina: general information (in Macedonian): https://acibademsistina.mk/mk/home/za_nas
- ClinicalTrials.gov: NCT04961996 (lidERA) locations: https://clinicaltrials.gov/study/NCT04961996
- ClinicalTrials.gov: NCT00567190 (CLEOPATRA) locations: https://clinicaltrials.gov/study/NCT00567190

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/), [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Lung cancer (all types)](https://onco.cc/cancers/lung-cancer/), [Prostate cancer](https://onco.cc/cancers/prostate/)
- institutions: [Agency for Medicines and Medical Devices (MALMED)](https://onco.cc/institutions/malmed-north-macedonia/), [PHI Clinical Hospital Dr Trifun Panovski, Bitola](https://onco.cc/institutions/clinical-hospital-bitola/), [University Clinic for Radiotherapy and Oncology, Skopje](https://onco.cc/institutions/university-clinic-radiotherapy-oncology-skopje/)
- trials: [A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies](https://onco.cc/trials/nct00781612/), [ALINA](https://onco.cc/trials/alina/), [CLEOPATRA](https://onco.cc/trials/cleopatra/), [lidERA](https://onco.cc/trials/lidera/)

---
JSON: https://onco.cc/api/v1/entities/acibadem-sistina-hospital.json